Anthony J. Roecker

3.3k citations

28 papers · 2.2k indexed · 1 hit paper · h-index 20

Organic Chemistry top 2%
Molecular Biology top 10%
Cognitive Neuroscience top 5%
Endocrine and Autonomic Systems top 1%
Experimental and Cognitive Psychology top 2%

Co-authors: Jeffrey A. Pfefferkorn K. C. Nicolaou Guoqiang Cao Sofía Barluenga Helen J. Mitchell Paul J. Coleman Christopher D. Cox Christopher J. Winrow
Topics: Sleep and Wakefulness Research (15 papers)Sleep and related disorders (12 papers)Circadian rhythm and melatonin (11 papers)
Cited by: Endocrine and Autonomic Systems Experimental and Cognitive Psychology Organic Chemistry
Journals: Journal of the American Chemical Society Molecular Cell Cancer Research
Partner nations: United States China Portugal

In The Last Decade

Anthony J. Roecker

28 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans

2000 580 citations K. C. Nicolaou, Jeffrey A. Pfefferkorn et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Anthony J. Roecker

Since Specialization

Citations

This map shows the geographic impact of Anthony J. Roecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Roecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Roecker more than expected).

Fields of papers citing papers by Anthony J. Roecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Roecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Roecker. The network helps show where Anthony J. Roecker may publish in the future.

Co-authorship network of co-authors of Anthony J. Roecker

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Roecker. A scholar is included among the top collaborators of Anthony J. Roecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Roecker. Anthony J. Roecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Building a Culture of Medicinal Chemistry Knowledge Sharing 2022 ·Journal of Medicinal Chemistry ·Douglas C. Beshore,Andrew M. Haidle,Ashok Arasappan,Yeon‐Hee Lim,Izzat T. Raheem,Anthony J. Roecker,(unknown),(unknown)	1
2	Discovery of Arylsulfonamide Na _v 1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile 2021 ·ACS Medicinal Chemistry Letters ·Anthony J. Roecker,M. E. Layton,(unknown),Michael J. Kelly,Thomas J. Greshock,Richard L. Kraus,Yuxing Li,Rebecca M. Klein,Michelle K. Clements,Christopher J. A. Daley,Aneta Jovanovska,Jeanine Ballard,Deping Wang,Fuqiang Zhao,Andrew P. J. Brunskill,Xuanjia Peng,Xiu Wang,Haiyan Sun,Andrea K. Houghton,Christopher S. Burgey	8
3	The dual orexin receptor antagonist, DORA‐22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine 2017 ·Journal of Neurochemistry ·Lihang Yao,Andres D. Ramirez,Anthony J. Roecker,Steven V. Fox,Jason M. Uslaner,Sean M. Smith,Robert A. Hodgson,Paul J. Coleman,John J. Renger,Christopher J. Winrow,Anthony L. Gotter	7
4	Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man 2016 ·Scientific Reports ·Anthony L. Gotter,Mark S. Forman,C. Meacham Harrell,Joanne Stevens,Vladimir Svetnik,Ka Lai Yee,Xiaodong Li,Anthony J. Roecker,Steven V. Fox,Pamela L. Tannenbaum,Susan L. Garson,Inge De Lepeleire,Nicole Calder,Laura Rosen,Arie Struyk,Paul J. Coleman,W. Joseph Herring,John J. Renger,Christopher J. Winrow	67
5	Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors 2016 ·Nature Structural & Molecular Biology ·Jie Yin,Kerim Babaoglu,Chad A. Brautigam,Lindsay Clark,Zhenhua Shao,Thomas H. Scheuermann,C. Meacham Harrell,Anthony L. Gotter,Anthony J. Roecker,Christopher J. Winrow,John J. Renger,Paul J. Coleman,Daniel M. Rosenbaum	111
6	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements 2015 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Swati P. Mercer,Jeffrey M. Bergman,Kevin F. Gilbert,Scott D. Kuduk,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Pamela L. Tannenbaum,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	14
7	Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis 2014 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Swati P. Mercer,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	9
8	Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement 2014 ·Behavioural Brain Research ·Jason M. Uslaner,Christopher J. Winrow,Anthony L. Gotter,Anthony J. Roecker,Paul J. Coleman,Pete H. Hutson,Anh D. Lê,John J. Renger	32
9	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Swati P. Mercer,Anthony J. Roecker,Susan L. Garson,Duane R. Reiss,C. Meacham Harrell,Kathy Murphy,Joseph G. Bruno,Rodney A. Bednar,Wei Lemaire,Donghui Cui,Tamara D. Cabalu,Cuyue Tang,Thomayant Prueksaritanont,George D. Hartman,Steven D. Young,Christopher J. Winrow,John J. Renger,Paul J. Coleman	19
10	Orexin receptors as therapeutic drug targets 2012 ·Progress in brain research ·Anthony L. Gotter,Anthony J. Roecker,Richard Hargreaves,Paul J. Coleman,Christopher J. Winrow,John J. Renger	79
11	Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman,John D. Schreier,Anthony J. Roecker,Swati P. Mercer,Georgia B. McGaughey,Christopher D. Cox,George D. Hartman,C. Meacham Harrell,Duane R. Reiss,Scott M. Doran,Susan L. Garson,Wayne B. Anderson,Cuyue Tang,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger	21
12	Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure 2009 ·Neuropharmacology ·Christopher J. Winrow,Keith Q. Tanis,Duane R. Reiss,Alison Rigby,Jason M. Uslaner,Victor N. Uebele,Scott M. Doran,Steven V. Fox,Susan L. Garson,Anthony L. Gotter,David Levine,Anthony J. Roecker,Paul J. Coleman,Kenneth S. Koblan,John J. Renger	61
13	Orexin Receptor Antagonists: Medicinal Chemistry and Therapeutic Potential 2008 ·Current Topics in Medicinal Chemistry ·Anthony J. Roecker,Paul J. Coleman	73
14	Proline bis-amides as potent dual orexin receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman,Anthony J. Roecker,Swati P. Mercer,Rodney A. Bednar,Duane R. Reiss,Richard W. Ransom,C. Meacham Harrell,Douglas J. Pettibone,Wei Lemaire,Kathy Murphy,Chunze Li,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger,Kenneth S. Koblan,George D. Hartman,Paul J. Coleman	54
15	Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP 2007 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Paul J. Coleman,Swati P. Mercer,John D. Schreier,Carolyn A. Buser,Eileen S. Walsh,Kelly Hamilton,Robert B. Lobell,Weikang Tao,Ronald E. Diehl,Vicki J. South,Joseph P. Davide,Nancy E. Kohl,Youwei Yan,Lawrence C. Kuo,Chunze Li,Carmen Fernández‐Metzler,Elizabeth Mahan,Thomayant Prueksaritanont,George D. Hartman	35
16	A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR 2003 ·Molecular Cell ·Michael Downes,Mark A. Verdecia,Anthony J. Roecker,Robert Hughes,John B. Hogenesch,Heidi R. Kast-Woelbern,M.E. Bowman,(unknown),Andrew M. Anisfeld,Peter A. Edwards,John M. Rosenfeld,Jacqueline G. Alvarez,Joseph P. Noel,K. C. Nicolaou,Ronald M. Evans	310
17	Discovery and Optimization of Non‐steroidal FXR Agonists from Natural Product‐Like Libraries. 2003 ·ChemInform ·K. C. Nicolaou,Ronald M. Evans,Anthony J. Roecker,Robert Hughes,Michael Downes,(unknown)	1
18	Discovery of Novel Antibacterial Agents Active Against Methicillin-ResistantStaphylococcus aureus from Combinatorial Benzopyran Libraries 2001 ·ChemBioChem ·K. C. Nicolaou,Anthony J. Roecker,Sofía Barluenga,Jeffrey A. Pfefferkorn,Guoqiang Cao	37
19	A Novel Strategy for the Solid-Phase Synthesis of Substituted Indolines 2000 ·Journal of the American Chemical Society ·K. C. Nicolaou,Anthony J. Roecker,Jeffrey A. Pfefferkorn,(unknown)	79
20	Natural Product-like Combinatorial Libraries Based on Privileged Structures. 2. Construction of a 10 000-Membered Benzopyran Library by Directed Split-and-Pool Chemistry Using NanoKans and Optical Encoding 2000 ·Journal of the American Chemical Society ·K. C. Nicolaou,Jeffrey A. Pfefferkorn,Helen J. Mitchell,Anthony J. Roecker,Sofía Barluenga,Guoqiang Cao,R.L. Affleck,(unknown)	216

About Anthony J. Roecker

Anthony J. Roecker is a scholar working on Endocrine and Autonomic Systems, Experimental and Cognitive Psychology and Cognitive Neuroscience, having authored 28 papers that have together received 2.2k indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (15 papers), Sleep and related disorders (12 papers) and Circadian rhythm and melatonin (11 papers). The work is most often cited by research in Endocrine and Autonomic Systems (444 citations), Experimental and Cognitive Psychology (413 citations) and Organic Chemistry (881 citations). Anthony J. Roecker has collaborated with scholars based in United States, China and Portugal. Frequent co-authors include Jeffrey A. Pfefferkorn, K. C. Nicolaou, Guoqiang Cao, Sofía Barluenga, Helen J. Mitchell, Paul J. Coleman, K. C. Nicolaou, Christopher D. Cox, Christopher J. Winrow and John J. Renger. Their work appears in journals such as Journal of the American Chemical Society, Molecular Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact